Dr Bruno Sangro Discusses Results for EMERALD-1 in Unresectable Hepatocellular Carcinoma
The study’s senior author discusses how the combined mechanisms of action produced benefit in progression-free survival.
Understanding AGAVE-201 and Unmet Need in Chronic GVHD